Medical Technology Assessment Committee

The Medical Technology Assessment Committee (MTAC) is responsible for systematically evaluating new medical technologies, new applications of existing technologies, and new uses of existing pharmaceuticals using an evidence-based process. Technologies include diagnostic tests, procedures, treatments, and devices for both medical and behavioral health that have implications for patient coverage.

MTAC includes a consumer representative, clinical leaders, epidemiologists, and representatives from specialty services, pharmacy and therapeutics, the legal department, clinical review and appeals, and community networks. The committee also seeks input from specialists and professionals relevant to the topic under review.

For current technologies under review or for supporting evidence on a prior decision, contact your Provider Services or Health Plan consultant.